These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 24158986

  • 1. Fibroblast growth factor-23 and cardiovascular events in CKD.
    Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE, Raj DS, Yang W, He J, Lash JP, Go AS, Kusek JW, Feldman H, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.
    J Am Soc Nephrol; 2014 Feb; 25(2):349-60. PubMed ID: 24158986
    [Abstract] [Full Text] [Related]

  • 2. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.
    Seiler S, Rogacev KS, Roth HJ, Shafein P, Emrich I, Neuhaus S, Floege J, Fliser D, Heine GH.
    Clin J Am Soc Nephrol; 2014 Jun 06; 9(6):1049-58. PubMed ID: 24677555
    [Abstract] [Full Text] [Related]

  • 3. Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.
    Deo R, Katz R, de Boer IH, Sotoodehnia N, Kestenbaum B, Mukamal KJ, Chonchol M, Sarnak MJ, Siscovick D, Shlipak MG, Ix JH.
    Am J Kidney Dis; 2015 Jul 06; 66(1):40-6. PubMed ID: 25572028
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis.
    Kestenbaum B, Sachs MC, Hoofnagle AN, Siscovick DS, Ix JH, Robinson-Cohen C, Lima JA, Polak JF, Blondon M, Ruzinski J, Rock D, de Boer IH.
    Circ Heart Fail; 2014 May 06; 7(3):409-17. PubMed ID: 24668259
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).
    Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ, Rifkin D, Siscovick DS, Sarnak MJ, Shlipak MG.
    J Am Coll Cardiol; 2012 Jul 17; 60(3):200-7. PubMed ID: 22703926
    [Abstract] [Full Text] [Related]

  • 9. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
    Smith K, deFilippi C, Isakova T, Gutiérrez OM, Laliberte K, Seliger S, Kelley W, Duh SH, Hise M, Christenson R, Wolf M, Januzzi J.
    Am J Kidney Dis; 2013 Jan 17; 61(1):67-73. PubMed ID: 22883134
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort.
    Dubin RF, Deo R, Bansal N, Anderson AH, Yang P, Go AS, Keane M, Townsend R, Porter A, Budoff M, Malik S, He J, Rahman M, Wright J, Cappola T, Kallem R, Roy J, Sha D, Shlipak MG, CRIC Study Investigators.
    Clin J Am Soc Nephrol; 2017 Jan 06; 12(1):60-68. PubMed ID: 28062676
    [Abstract] [Full Text] [Related]

  • 12. Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD Study.
    Matsui M, Uemura S, Takeda Y, Samejima K, Matsumoto T, Hasegawa A, Tsushima H, Hoshino E, Ueda T, Morimoto K, Okamoto K, Okada S, Onoue K, Okayama S, Kawata H, Kawakami R, Maruyama N, Akai Y, Iwano M, Shiiki H, Saito Y, NARA-CKD Investigators.
    J Am Soc Nephrol; 2015 Nov 06; 26(11):2871-81. PubMed ID: 25788536
    [Abstract] [Full Text] [Related]

  • 13. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C, Katz R, Alam M, Bhat Z, Bellovich K, de Boer I, Brosius F, Gadegbeku C, Gipson D, Hawkins J, Himmelfarb J, Ju W, Kestenbaum B, Kretzler M, Robinson-Cohen C, Steigerwalt S, Bansal N.
    Am J Kidney Dis; 2018 Oct 06; 72(4):519-528. PubMed ID: 29866459
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
    Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M.
    Circulation; 2009 May 19; 119(19):2545-52. PubMed ID: 19414634
    [Abstract] [Full Text] [Related]

  • 15. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
    Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Group.
    JAMA; 2011 Jun 15; 305(23):2432-9. PubMed ID: 21673295
    [Abstract] [Full Text] [Related]

  • 16. The importance of proteinuria and prior cardiovascular disease in all major clinical outcomes of atherosclerotic renovascular disease - a single-center observational study.
    Vassallo D, Ritchie J, Green D, Chrysochou C, Blunt J, Kalra PA.
    BMC Nephrol; 2016 Dec 07; 17(1):198. PubMed ID: 27927187
    [Abstract] [Full Text] [Related]

  • 17. Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.
    Seiler-Mussler S, Limbach AS, Emrich IE, Pickering JW, Roth HJ, Fliser D, Heine GH.
    Clin J Am Soc Nephrol; 2018 Apr 06; 13(4):569-576. PubMed ID: 29507005
    [Abstract] [Full Text] [Related]

  • 18. Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.
    Drew DA, Katz R, Kritchevsky S, Ix JH, Shlipak MG, Newman AB, Hoofnagle A, Fried L, Sarnak MJ, Gutierrez OM.
    Am J Nephrol; 2018 Apr 06; 47(4):242-250. PubMed ID: 29621752
    [Abstract] [Full Text] [Related]

  • 19. Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study.
    Lutsey PL, Alonso A, Selvin E, Pankow JS, Michos ED, Agarwal SK, Loehr LR, Eckfeldt JH, Coresh J.
    J Am Heart Assoc; 2014 Jun 10; 3(3):e000936. PubMed ID: 24922628
    [Abstract] [Full Text] [Related]

  • 20. Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure.
    Wohlfahrt P, Melenovsky V, Kotrc M, Benes J, Jabor A, Franekova J, Lemaire S, Kautzner J, Jarolim P.
    JACC Heart Fail; 2015 Oct 10; 3(10):829-39. PubMed ID: 26450001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.